Milan Paleja, vice chairman and managing director of Novartis India, is moving on, just months after taking over the top job at the Swiss multinational’s Indian operations.
Revolving Door: Novartis India Managing Director Quits
Novartis India’s managing director has quit - the second time in 2018 that the Swiss multinational finds the corner office vacated.
More from Business
More from Scrip
• By
DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.
• By
Biogen expects little impact from existing tariffs and any that may apply if the US exemption of pharma products is lifted, since 75% of its manufacturing is in the US and 55% of sales are ex-US.
• By
MariTide could give Amgen a big boost if successful in obesity, but the drug just entered Phase III. Even so, Q1 revenue rose 9% to $8.15bn and more growth is expected in 2025.